Rafael Holdings Inc's Income per employee grew in the third quarter 2026 on a trailing twelve month basis to $ 1,125,652, the income was higher than average, indicating higher productivity of the company's employees.
The Healthcare sector has seen employees of 18 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 169, from total ranking in previous quarter at 173.

What is Income per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Net Income per Employee▼

None ▼

Net Income per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RFL Net Income per Employee	(Apr 30 2026) III. Quarter	(Jan 31 2026) 2026	(Oct 31 2025) I. Quarter	(Jul 31 2025) IV. Quarter	(Apr 30 2025) III. Quarter
Y / Y Net Income Change	-	-	-	-	-
Net Income per Employee (TTM) $	1,125,652	1,075,522	1,119,000	1,144,478	-1,019,261
RFL's Total Ranking	# 169	# 173	# 170	# 3414	# 3829
Seq. Net Income Change	-	-	-	-	-

RFL Company Profile >> Back to RFL Efficiency Comparisons >> Compare RFL Net Income per Employee to its Competitors

RFL Net Income per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 19
Healthcare Sector	# 25
Overall Market	# 169

Net Income per Employee Statistics
High	Average	Low
$ 1,224,609	$ -1,312,169	$ -6,631,478
(Apr 30 2026)		(Oct 31 2021)

Companies with similar Income per Employee for 12 month ending Apr 30 2026, within Healthcare Sector	Income per Employee	Income 12 month ending Apr 30 2026	Number of Employees Apr 30 2026
Elutia Inc	1,917,076.92	$ 49.844 Million	26
Fortress Biotech Inc	1,653,051.28	$ 128.938 Million	78
Pulmatrix Inc	1,612,500.00	$ 3.225 Million	2
Exelixis Inc	1,601,241.50	$ 1,836.624 Million	1,147
Xoma Royalty Corporation	1,423,714.29	$ 19.932 Million	14
Q32 Bio Inc	1,385,125.00	$ 33.243 Million	24
Petros Pharmaceuticals inc	1,289,601.00	$ 3.869 Million	3
Theravance Biopharma inc	1,272,677.78	$ 114.541 Million	90
Coherus Oncology inc	1,267,115.65	$ 186.266 Million	147
Rafael Holdings Inc	1,224,608.70	$ 28.166 Million	23
Catalyst Pharmaceuticals Inc	1,216,060.44	$ 221.323 Million	182
Tg Therapeutics Inc	1,157,634.09	$ 461.896 Million	399
Glucotrack Inc	1,125,933.33	$ 16.889 Million	15
Ironwood Pharmaceuticals inc	1,021,760.00	$ 102.176 Million	100
Silexion Therapeutics Corp	922,142.86	$ 12.910 Million	14
United Therapeutics Corporation	919,571.43	$ 1,287.400 Million	1,400
Emmis Acquisition Corp	906,895.50	$ 1.814 Million	2
Halozyme Therapeutics Inc	824,687.94	$ 348.843 Million	423
Prestige Consumer Healthcare Inc	785,608.77	$ 447.797 Million	570
Agenus Inc	771,518.52	$ 62.493 Million	81
Krystal Biotech Inc	762,813.56	$ 225.030 Million	295
Elite Pharmaceuticals Inc	690,349.02	$ 44.873 Million	65
Illumina Inc	666,406.25	$ 853.000 Million	1,280
Engene Therapeutics Inc	623,048.78	$ 51.090 Million	82
Spero Therapeutics Inc	609,400.00	$ 15.235 Million	25
Amgen Inc	600,000.00	$ 7,800.000 Million	13,000
Vaxart Inc	570,723.08	$ 37.097 Million	65

Date modified: 2026-09-08T15:11:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.